These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 345575)

  • 1. [Screening for mutagenic and carcinogenic effects using microogranisms].
    Kiel P; Maxild J
    Ugeskr Laeger; 1978 Mar; 140(13):705-8. PubMed ID: 345575
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutagenic-carcinogenic relationships and the role of mutagenic screening tests for carcinogenicity.
    Poirier LA; Simmon VF
    Clin Toxicol; 1976; 9(5):761-71. PubMed ID: 793761
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro mutagenicity assays of chemical carcinogens and related compounds with Salmonella typhimurium.
    Simmon VF
    J Natl Cancer Inst; 1979 Apr; 62(4):893-9. PubMed ID: 372657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical review: will the Ames Salmonella assay system be used as a screen for presumptive carcinogens?
    Jacobs M
    J Environ Pathol Toxicol; 1979; 2(4):1205-15. PubMed ID: 376768
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemical characterization of 465 known or suspected carcinogens and their correlation with mutagenic activity in the Salmonella typhimurium system.
    Rinkus SJ; Legator MS
    Cancer Res; 1979 Sep; 39(9):3289-318. PubMed ID: 383284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenic activity of chemical carcinogens and related compounds in the intraperitoneal host-mediated assay.
    Simmon VF; Rosenkranz HS; Zeiger E; Poirier LA
    J Natl Cancer Inst; 1979 Apr; 62(4):911-8. PubMed ID: 372659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of chemical mutagens use of concentration gradient plates in a high capacity screen.
    Cline JC; McMahon RE
    Res Commun Chem Pathol Pharmacol; 1977 Mar; 16(3):523-33. PubMed ID: 322226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A correlation between mutagenic and carcinogenic potencies in a diverse group of N-nitrosamines: determination of mutagenic activities of weakly mutagenic N-nitrosamines.
    Lee SY; Guttenplan JB
    Carcinogenesis; 1981; 2(12):1339-44. PubMed ID: 7034988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro screening of carcinogens using DNA of the His- mutant of Salmonella typhimurium.
    Beljanski M; Le Goff L; Beljanski M
    Exp Cell Biol; 1982; 50(5):271-80. PubMed ID: 6754496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mutagenic and carcinogenic actions of some polycyclic aromatic hydrocarbons].
    Linnik AB; Tolcheev IuD; Khitrova IA
    Biull Eksp Biol Med; 1979 Nov; 88(11):592-5. PubMed ID: 395973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Predictive value of short-term assays of chemical carcinogenesis].
    Laborda E; de la Peña E; Valcarce E; Canga C; Sladek F; Barrueco C
    Rev Esp Oncol; 1982; 29(3):547-55. PubMed ID: 6765349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic activation and deactivation of mutagens and carcinogens.
    De Flora S
    Ital J Biochem; 1979; 28(2):81-103. PubMed ID: 399955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assay of 855 test chemicals in ten tester strains using a new modification of the Ames test for bacterial mutagens.
    McMahon RE; Cline JC; Thompson CZ
    Cancer Res; 1979 Mar; 39(3):682-93. PubMed ID: 371791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in sensitivity to mutagens and a tumour promoter in bacteria grown in continuous culture [proceedings].
    Anstice AM; Soper CJ
    J Pharm Pharmacol; 1979 Dec; 31 Suppl():69P. PubMed ID: 42746
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of the mutagenicity of compounds of known carcinogenicity, belonging to the benz[a]anthracene, chrysene, and cyclopenta[a]phenanthrene series, using Ames's test.
    Coombs MM; Dixon C; Kissonerghis AM
    Cancer Res; 1976 Dec; 36(12):4525-9. PubMed ID: 793712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay for mutagenicity of bile in Sprague-Dawley rats treated subcutaneously with intestinal carcinogens.
    Moriya M; Ohta T; Sugiyama F; Miyazawa T; Shirasu Y
    J Natl Cancer Inst; 1979 Oct; 63(4):977-82. PubMed ID: 384011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-arabinose resistance test with Salmonella typhimurium as a primary tool for carcinogen screening.
    Dorado G; Pueyo C
    Cancer Res; 1988 Feb; 48(4):907-12. PubMed ID: 3276401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutagenicity of several classes of antitumor agents to Salmonella typhimurium TA98, TA100, and TA92.
    Seino Y; Nagao M; Yahagi T; Hoshi A; Kawachi T; Sugimura T
    Cancer Res; 1978 Jul; 38(7):2148-56. PubMed ID: 350383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The new SOS chromotest (CEA test) for demonstrating mutagens and promutagens based on the indicator strain Salmonella typhimurium TA1535].
    Egorov IA; Svistunova GL; Darkazanli K; Kalinina LM; Tarasov VA
    Dokl Akad Nauk SSSR; 1991; 318(5):1230-2. PubMed ID: 1914822
    [No Abstract]   [Full Text] [Related]  

  • 20. Mutagenicity of N-nitrosopiperazines for Salmonella typhimurium in the host-mediated assay.
    Zeiger E; Legator MS; Lijinsky W
    Cancer Res; 1972 Jul; 32(7):1598-9. PubMed ID: 4555385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.